Generic Name |
||
---|---|---|
IND |
MSC1936369B + SAR245409 | |
Brand Name (US) |
||
Manufacturer |
EMD Serono | |
Drug Type |
||
Delivery |
Oral | |
Approval Status |
||
Indications |
||
Overall Strategy |
Oncogenic Signal Path Based | |
Strategy |
Block related tumor signal paths | |
Drug Category |
PI3K inhibitor + MEK inhibitor |
Links |
|
Trials of this drug |
|
|
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors |
Trial results |